MSD’s antiviral drug hits endpoint targets in Phase III trials
October 20, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AiCuris, MSD, Merck, bone marrow, letermovir, transplant
MSD, known as Merck in the US, released news of the successful meeting of its primary endpoints in its Phase …
Oxford Genetics boosts cell/gene therapy R&D with new facility
October 20, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oxford Genetics, expansion
Oxford Genetics has moved its operations to the Medawar centre in the city, upscaling its infrastructure and staff to keep …
Specialist Clinical Trials Equipment Supplier Woodley Equipment Company Exhibiting at OCT Southern California
October 19, 2016Woodley Equipment is exhibiting at Outsourcing in Clinical Trials Southern California taking place on 26th and 27th October 2016 at …
Sun Pharma partners with ICGEB to develop dengue vaccine
October 19, 2016Research and Development Vaccine, dengue, icgeb, sun pharmaceutical
Indian drug firm Sun Pharma is set to join forces with the International Centre for Generic Engineering and Biotechnology (ICGEB) …
Lilly announces plan to expand global access to health care
October 19, 2016Research and Development Eli Lilly, Lilly 30x30, global health
Eli Lilly has announced a project, known as Lilly 30×30, which is a five-year, $90 million investment to improve access …
Roche’s immunotherapy cancer drug given FDA approval
October 19, 2016Research and Development Cancer, FDA, Genentech, Roche, immunotherapy, lung cancer
Coming off the back of earlier positive news this month, Roche has revealed that their drug, Tecentriq, has been given …
Recipharm to open largest Nordic GLP bioanalysis lab
October 19, 2016Manufacturing and Production, Research and Development Recipharm, Sweden, expansion
Contract development and manufacturing firm Recipharm has announced plans to invest five million Swedish Krona (SEK) in a new GLP-compliant …
FDA grants $23 million to boost research on rare diseases
October 19, 2016Research and Development Cancer, FDA, clinical trials, oncology
The FDA has continued their push to provide funding for experimental clinical trials into treatments of rare diseases. The FDA, …
Quark to set up “largest biotechnology fund in Canada” for $500m
October 18, 2016Manufacturing and Production, Research and Development Canada, Quark Venture, Vancouver, fund
Canadian venture capital firm Quark Venture is to partner up with China’s GF Securities to launch a “largest of its …
Research suggests that anti-inflammatory drugs may offer alternative to anti-depressants
October 18, 2016Manufacturing and Production University of Cambridge, anti-cytokine, anti-inflammatory, depression
Researchers at the University of Cambridge analysed data from 20 clinical trials involving anti-cytokine drugs, which are commonly used to …
IBM and Quest forge precision cancer treatment partnership
October 18, 2016Manufacturing and Production, Medical Communications Cancer, Precision Medicine, Quest, ibm, oncology
IBM has revealed it is to join forces with clinical laboratory service provider Quest Diagnostics in a bid to utilise …
Pfizer sets release date for rival to J&J’s blockbuster drug
October 18, 2016Manufacturing and Production J&J, JJ, Johnson & Johnson, Pfizer, Remicade, inflectra
Pfizer have announced that they will begin shipping their rival to Johnson & Johnson’s Remicade by the end of November. …
Regeneron and Teva’s experimental drug halted by FDA clinical hold
October 17, 2016Manufacturing and Production Regeneron, Teva, back pain, osteoarthritis
Regeneron Pharmaceuticals and Teva Pharmaceuticals had only just agreed a deal worth a potential $2.6 billion to co-develop Regeneron’s fasinumab …
Wickham Laboratories Announces Renewal of FDA Accreditation
October 17, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Wickham Laboratories announces that the United States Food and Drug Administration (FDA) inspection conducted 15th-17th of February 2016 has now …
Apitope reclaims multiple sclerosis treatment from Merck after 7 years
October 17, 2016Sales and Marketing ATX-MS-1467, Apitope, Merck, multiple sclerosis
Apitope has announced it has reclaimed the global rights to its multiple sclerosis (MS) treatment ATX-MS-1467 from Merck for the …
Valeant Pharmaceutical release their latest price increases
October 17, 2016Sales and Marketing
Valeant Pharmaceutical announced, on 14 October, that their Patient Access and Pricing Committee had decided on a price range increase …
Hanmi Pharmaceutical raided over insider trading suspicions
October 17, 2016Sales and Marketing Boehringer Ingelheim, Genentech, Hanmi Pharmaceutical, south korea
At the end of September, we reported on a busy 24-hour for Hanmi Pharmaceutical, as they secured a deal with …
EMA grants conditional approval for biliary cholangitis treatment
October 17, 2016Sales and Marketing EMA, intercept, ocaliva, primary biliary cholangitis
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has voiced its approval of Intercept’s Ocaliva …
Celgene trial displays promising results for Crohn’s disease alternative treatment
October 17, 2016Sales and Marketing Celgene, Celgene corporation, Crohn’s disease, clinical trials, crohn's disease, phase I, trial
Celgene International, part of Celgene Corporation, has released the results from a Phase Ib trial showing improvement in patients suffering …
Kite Pharma appoints Chris Nowers as Head of Europe
October 14, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Nowers, London, kite pharma
Kite Pharma announced on 13 October that it had appointed Chris Nowers as its Head of Europe. Nowers will be …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
